No families affected by tuberculosis to face catastrophic costs by 2020: India's new strategic plan to eliminate tuberculosis

Indian J Tuberc. 2019 Apr;66(2):219-221. doi: 10.1016/j.ijtb.2019.04.009. Epub 2019 Apr 13.

Authors

Malaisamy Muniyandi¹, Rajeswari Ramachandran²

Affiliations

¹ Department of Health Economics, National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, India. Electronic address: mmuniyandi@yahoo.com.
² Department of Clinical Research, National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, India; Dr Kamakshi Memorial Hospital, Chennai, India.

PMID: 31151487
DOI: 10.1016/j.ijtb.2019.04.009

No abstract available

Publication types

Editorial

MeSH terms

Antitubercular Agents / therapeutic use
Cost of Illness*
Delayed Diagnosis
Delivery of Health Care
Disease Eradication*
Health Expenditures*
Humans
India
Medication Adherence
Poverty
Quality of Health Care
Tuberculosis / economics*
Tuberculosis / prevention & control*

Substances

Antitubercular Agents